Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study - Gould, Doug W; Doidge, James; Sadique, M Zia; Borthwick, Mark; Hatch, Robert; Caskey, Fergus J; Forni, Lui; Lawrence, Robert F; MacEwen, Clare; Ostermann, Marlies; Mouncey, Paul R; Harrison, David A; et al. (Health technology assessment (Winchester, England), 2022)
Keywords: Adult; anticoagulants; Anticoagulants - adverse effects; Citric Acid; Continuous Renal Replacement Therapy; Cost-Benefit Analysis; Critical Care; heparin; Heparin - adverse effects; Humans; intensive care; length of stay; Quality of Life; routine data; COST–BENEFIT ANALYSIS; CITRIC ACID; ANTICOAGULANTS; INTENSIVE CARE; LENGTH OF STAY; CONTINUOUS RENAL REPLACEMENT THERAPY; ROUTINE DATA; CRITICAL CARE; HEPARIN